Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2013; 19(9): 1387-1395
Published online Mar 7, 2013. doi: 10.3748/wjg.v19.i9.1387
Published online Mar 7, 2013. doi: 10.3748/wjg.v19.i9.1387
Figure 3 Patients with ribavirin dose reduction.
Percentage of patients who had ribavirin (RBV) dose reduction during the first 12 wk of the combination treatment: It was significantly higher in the CC than in the non-CC genotype groups.
- Citation: Ahmed WH, Furusyo N, Zaky S, Sharaf Eldin A, Aboalam H, Ogawa E, Murata M, Hayashi J. Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients. World J Gastroenterol 2013; 19(9): 1387-1395
- URL: https://www.wjgnet.com/1007-9327/full/v19/i9/1387.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i9.1387